One of the most common treatments for diffuse large B-cell lymphoma is R-CHOP. It combines the monoclonal antibody drug rituximab with three chemotherapy drugs and a corticosteroid. This treatment is safe and effective but doesn’t always work or …

Diffuse large B-cell lymphoma (DLBCL) tends to grow quickly. Most often, the treatment is chemotherapy (chemo), usually with 4 drugs known as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), plus the monoclonal antibody rituximab (Rituxan).

Since DLBCL can advance quickly, it usually requires immediate treatment. A combination of chemotherapy and the monoclonal antibody rituximab (Rituxan), with or without radiation therapy, can lead to disease remission in a large number of patients with this form of lymphoma.

2024年4月15日 · Mayo Clinic expert Grzegorz Nowakowski, M. D., explains that diffuse large B-cell lymphoma is potentially curable. New, more effective drugs and agents make this an exciting time for treatment.

2024年6月26日 · CAR T-cell therapy is a potentially lifesaving treatment for diffuse large B-cell lymphoma offers patients hope after other treatments fail. Here, we walk you through the process.

2024年2月29日 · Advancements in diffuse large B-cell lymphoma (DLBCL) treatment may improve outcomes for people living with this type of cancer.

2024年4月23日 · Several types of third-line treatments for DLBCL are available. The treatment plan for a specific person depends on several factors, such as past therapies and overall health. When appropriate, the preferred therapies for third-line treatment are CAR-T cell therapy and bispecific antibody therapy.

2024年2月22日 · Diffuse large B-cell lymphoma (DLBCL) is a subtype of non-Hodgkin’s lymphoma. Though many people will respond to first-line treatment options, many will experience refractory or relapsed...

2020年9月29日 · As with many blood cancers, the first line treatment for DLBCL is chemotherapy. In most cases, patients receive a combination of five medications, known as R-CHOP. R-CHOP, or other more intense treatment combinations, is often successful in curing DLBCL.

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). It is an aggressive (fast-growing), but treatable, lymphoma that starts in B cells. There are many different subtypes of DLBCL.